Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Palisade Bio, Inc. - Common Stock
(NQ:
PALI
)
2.010
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Palisade Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
January 02, 2023
Via
Benzinga
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1%
↗
December 30, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
December 30, 2022
Via
Benzinga
Palisade Bio Voluntarily Ceases Enrollment In Its Lead Program Study
↗
December 16, 2022
Via
Benzinga
Why Is Palisade Bio (PALI) Stock Up 130% Today?
↗
November 22, 2022
Today's rally in PALI stock appears to be tied directly to an FDA announcement that it's fast tracking a key drug from the company.
Via
InvestorPlace
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
↗
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the...
Via
Benzinga
Stocks Firmly On Track For Worst Year Since 2008
↗
December 30, 2022
The last day of 2022 is offering no reprieve to investors, with the major indexes still on track for their worst year since 2008, after months of persistent inflation and aggressive interest rate...
Via
Talk Markets
Nasdaq Falls 100 Points; Dermata Therapeutics Shares Surge
↗
December 30, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Friday.
Via
Benzinga
US Stocks Open Lower; Dow Drops 250 Points
↗
December 30, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 30, 2022
Via
Benzinga
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
↗
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 29, 2022
Via
Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
↗
December 29, 2022
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
December 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
December 23, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Peering Into Palisade Bio's Recent Short Interest
↗
December 12, 2022
Palisade Bio's (NASDAQ:PALI) short percent of float has risen 14313.64% since its last report. The company recently reported that it has 428 thousand shares sold short, which is 31.71% of all regular...
Via
Benzinga
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
December 07, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
December 01, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
↗
November 23, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday.
Via
Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
↗
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Via
Benzinga
Dow Jumps Over 300 Points; S&P 500 Rises 1%
↗
November 22, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday.
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
↗
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148
November 22, 2022
Palisade Bio, Inc. (NASDAQ: PALI) is engaged as a biopharmaceutical company, which is focused on the research and development of
Via
Spotlight Growth
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
↗
November 22, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 22, 2022
Via
Benzinga
US Stocks Open Higher As Dow Surges 250 Points
↗
November 22, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday.
Via
Benzinga
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
November 22, 2022
From
Palisade Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
